Drug General Information
Drug ID
D04MCY
Former ID
DCL001160
Drug Name
BMS 650032
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 2 [550384]
Company
Bristol-Myers Squibb
Structure
Download
2D MOL

3D MOL

Formula
C35H46ClN5O9S
Canonical SMILES
CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C<br />3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C
InChI
1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1
InChIKey
XRWSZZJLZRKHHD-WVWIJVSJSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [550384]
References
Ref 5503842011 Pipeline of Bristol-Myers Squibb.
Ref 5503842011 Pipeline of Bristol-Myers Squibb.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.